4//SEC Filing
Maynard Ryan D 4
Accession 0001179110-17-013850
CIK 0001034842other
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 9:07 PM ET
Size
8.1 KB
Accession
0001179110-17-013850
Insider Transaction Report
Form 4
Maynard Ryan D
VP, CFO
Transactions
- Exercise/Conversion
Common Stock
2017-11-03$2.14/sh+100,000$214,000→ 100,000 total - Sale
Common Stock
2017-11-03$3.90/sh−100,000$390,000→ 0 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-11-03−100,000→ 75,000 totalExercise: $2.14Exp: 2025-01-26→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2017.
- [F2]The option vested monthly over two years from January 1, 2015.
Documents
Issuer
RIGEL PHARMACEUTICALS INC
CIK 0001034842
Entity typeother
Related Parties
1- filerCIK 0001363984
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 9:07 PM ET
- Size
- 8.1 KB